Breaking News Instant updates and real-time market news.

CVX

Chevron

$117.20 /

-0.88 (-0.75%)

, COP

ConocoPhillips

$60.16 /

-0.18 (-0.30%)

12:04
11/30/19
11/30
12:04
11/30/19
12:04

Barron's suggests four cheap energy stocks, despite sector's unpopularity

Barron's Andrew Bary noted that the deeply unpopular energy sector is having a "harder time attracting investors," and added that there is a "baby boomer/millennial divide, with younger investors more uncomfortable with energy stocks." However, Mark Stoeckle, CEO of Adams Funds, argued that the energy industry is quickly evolving due to investor pressure, with "nearly every major company emphasizing capital discipline and boosting returns to shareholders through dividends and stock buybacks." Stoeckle said, "More money is coming back to shareholders and less is going into the ground. At some point in the next 10 years, that will present an opportunity. Unless global demand falls off, there won't be enough oil and gas to meet demand." He recommended Chevron (CVX), ConocoPhillips (COP), BP (BP), and Total (TOT). Reference Link

CVX

Chevron

$117.20 /

-0.88 (-0.75%)

COP

ConocoPhillips

$60.16 /

-0.18 (-0.30%)

BP

BP

$37.45 /

-0.3 (-0.79%)

TOT

Total

$52.54 /

-0.35 (-0.66%)

CVX Chevron
$117.20 /

-0.88 (-0.75%)

10/31/19
BP downgraded to Hold at Argus on rising debt levels
10/15/19 Cowen
Chevron weakness a buying opportunity, says Cowen
08/20/19 BMO Capital
BMO Capital starts Chevron at Outperform with $165 price target
08/20/19 BMO Capital
Chevron initiated with an Outperform at BMO Capital
COP ConocoPhillips
$60.16 /

-0.18 (-0.30%)

11/22/19 JPMorgan
ConocoPhillips price target raised to $74 from $70 at JPMorgan
10/11/19 Goldman Sachs
Goldman Sachs positive on ConocoPhillips ahead of Q3 report
09/17/19 UBS
ConocoPhillips upgraded to Buy from Neutral at UBS
09/16/19 UBS
ConocoPhillips upgraded to Buy from Neutral at UBS
BP BP
$37.45 /

-0.3 (-0.79%)

11/01/19
Rice University-Jones Graduate School of Business to hold a summit
10/31/19 Argus
BP downgraded to Hold from Buy at Argus
09/16/19 JPMorgan
JPMorgan bullish on European oil stocks, sees demand 4% by 2040
TOT Total
$52.54 /

-0.35 (-0.66%)

09/16/19 JPMorgan
Total upgraded to Overweight from Neutral at JPMorgan
08/22/19 Citi
Total downgraded to Neutral from Buy at Citi
08/20/19
Total initiated with a Market Perform at BMO Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Marathon Petroleum refinery in Los Angeles in flames after explosion » 05:30
02/26/20
02/26
05:30
02/26/20
05:30
MPC

Marathon Petroleum

$53.09 /

-2.78 (-4.98%)

A Marathon Petroleum…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Home Depot price target raised to $270 from $245 at Stifel » 05:26
02/26/20
02/26
05:26
02/26/20
05:26
HD

Home Depot

$237.41 /

-2.36 (-0.98%)

Stifel analyst John Baugh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Volaris reports Q4 EPS 68c, may not compare to consensus (2c) » 05:25
02/26/20
02/26
05:25
02/26/20
05:25
VLRS

Volaris

$12.33 /

-0.19 (-1.52%)

Reports Q4 revenue $516M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
GW Pharmaceuticals Q1 guidance 'overly conservative,' says Piper Sandler » 05:24
02/26/20
02/26
05:24
02/26/20
05:24
GWPH

GW Pharmaceuticals

$116.77 /

-4.1 (-3.39%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Campbell Soup reinstated with a Neutral at Goldman Sachs » 05:18
02/26/20
02/26
05:18
02/26/20
05:18
CPB

Campbell Soup

$47.87 /

-0.15 (-0.31%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Insulet should be bought on selloff from guidance, says Piper Sandler » 05:14
02/26/20
02/26
05:14
02/26/20
05:14
PODD

Insulet

$197.03 /

-10.46 (-5.04%)

Insulet last night…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Salesforce results strong across the board, says Jefferies » 05:11
02/26/20
02/26
05:11
02/26/20
05:11
CRM

Salesforce

$181.65 /

-4.26 (-2.29%)

Salesforce last night…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Evolent Health price target raised to $17 from $10.15 at Piper Sandler » 05:07
02/26/20
02/26
05:07
02/26/20
05:07
EVH

Evolent Health

$10.18 /

-1.13 (-9.99%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Regeneron downgraded to Neutral from Outperform at Baird » 05:04
02/26/20
02/26
05:04
02/26/20
05:04
REGN

Regeneron

$442.34 /

+16.05 (+3.77%)

, NVS

Novartis

$88.01 /

-2.06 (-2.29%)

Baird analyst Brian…

Baird analyst Brian Skorney downgraded Regeneron Pharmaceuticals (REGN) to Neutral from Outperform with an unchanged price target of $410. The stock closed Tuesday up 4% to $442.35. The analyst appreciates the "tailwind granted by safety concerns" related to Eylea competitor, Novartis' (NVS) Beovu, he notes the shares are up 50% since his August 2019 upgrade. While the fall of Beovu certainly near-term pressure on Eylea market share, this has now been accounted for in the share price, Skorney tells investors in a research note. Skorney adds that while Dupixent and Regeneron's pipeline "continue to look good," he prefers to take a "wait and see approach."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Intercept upgraded to Buy from Neutral at Citi » 04:58
02/26/20
02/26
04:58
02/26/20
04:58
ICPT

Intercept

$84.52 /

-6.25 (-6.89%)

Citi analyst Joel Beatty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
E-Trade downgraded to Market Perform from Outperform at Raymond James » 04:56
02/26/20
02/26
04:56
02/26/20
04:56
ETFC

E-Trade

$48.52 /

-1.88 (-3.73%)

, MS

Morgan Stanley

$48.02 /

-1.65 (-3.32%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Toll Brothers downgraded to Market Perform from Outperform at Raymond James » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
TOL

Toll Brothers

$44.28 /

-2.765 (-5.88%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
nLight management to meet with Craig-Hallum » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
LASR

nLight

$16.30 /

-0.61 (-3.61%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Cerence management to meet with Oppenheimer » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
CRNC

Cerence

$26.49 /

-0.16 (-0.60%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Flowserve management to meet with RBC Capital » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
FLS

Flowserve

$41.75 /

-1.82 (-4.18%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Week of 2/21 MBA Mortgage Applications to be released at 07:00  04:55
02/26/20
02/26
04:55
02/26/20
04:55
 
Conference/Events
Ares Capital management to meet with JPMorgan » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
ARCC

Ares Capital

$17.86 /

-0.815 (-4.36%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
HyreCar management to meet with Susquehanna » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
HYRE

HyreCar

$3.63 /

-0.16 (-4.22%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
MKS Instruments management to meet with KeyBanc » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
MKSI

MKS Instruments

$101.93 /

-3.16 (-3.01%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Vocera management to meet with RBC Capital » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
VCRA

Vocera

$26.64 /

+0.59 (+2.26%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
IFF management to meet with UBS » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
IFF

IFF

$124.00 /

-3.92 (-3.06%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 7 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Amedisys management to meet with SunTrust » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
AMED

Amedisys

$184.73 /

-7.87 (-4.09%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Jack Henry management to meet with Stephens » 04:55
02/26/20
02/26
04:55
02/26/20
04:55
JKHY

Jack Henry

$163.71 /

-4.39 (-2.61%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Week of 2/21 EIA Petroleum Status Report to be released at 10:30  04:55
02/26/20
02/26
04:55
02/26/20
04:55
 
General news
Week of 2/21 MBA Mortgage Applications to be released at 07:00  04:55
02/26/20
02/26
04:55
02/26/20
04:55
 

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.